Physician
Garden City Treatment Center, INC.
Garden City Treatment Center, INC. was paid $6.39M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoGARDEN CITY TREATMENT CENTER, INC.
CRANSTON, RI 02920
CRANSTON, RI 02920
33aNPI1306954425assigned 08/28/2006
33bProvider typeEmergency Medical Services (Emergency Medicine) Physician
28Total paid$6.39M
24GClaims158,752
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medical Services (Emergency Medicine) Physician providers in Rhode Island
Rank by total paid#2 of 13
Median peer was paid$280K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,539 | $871K | |
| 2019 | 22,162 | $965K | |
| 2020 | 14,904 | $610K | |
| 2021 | 20,259 | $927K | |
| 2022 | 26,252 | $1.09M | |
| 2023 | 28,671 | $1.04M | |
| 2024incomplete | 27,965 | $888K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 38,560 | 35,598 | $1.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 21,699 | 20,347 | $1.33M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 18% | 14,527 | 14,170 | $1.14M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 9.0% | 16,921 | 16,442 | $574K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.8% | 3,504 | 3,339 | $372K |
| 71046 | Radiologic examination, chest; 2 views | 5.1% | 11,591 | 11,049 | $329K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.0% | 20,775 | 10,120 | $255K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 9,170 | 8,851 | $115K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 2,447 | 2,281 | $76K |
| 70210 | 1.2% | 3,696 | 3,463 | $75K | |
| 72100 | <1% | 2,486 | 2,399 | $59K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,159 | 1,075 | $58K |
33 more codes
| 72040 | <1% | 2,464 | $52K | |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 239 | $47K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 628 | $32K |
| 74018 | <1% | 1,214 | $27K | |
| 73610 | <1% | 793 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 953 | $16K |
| 93000 | <1% | 847 | $15K | |
| 73630 | <1% | 769 | $14K | |
| L0627 | Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 49 | $12K |
| 92567 | <1% | 789 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 571 | $11K |
| 99201 | <1% | 321 | $10K | |
| 73562 | <1% | 329 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 122 | $9K |
| 73030 | <1% | 421 | $8K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 293 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 265 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 129 | $6K |
| 86328 | <1% | 80 | $4K | |
| 73110 | <1% | 136 | $3K | |
| 73560 | <1% | 110 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 54 | $2K |
| L1810 | Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 26 | $2K |
| 73130 | <1% | 87 | $2K | |
| 90715 | <1% | 24 | $900.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 56 | $877.92 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $650.00 |
| 72070 | <1% | 29 | $569.08 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $520.00 |
| 81003 | <1% | 320 | $467.22 | |
| 74022 | <1% | 16 | $411.18 | |
| 94664 | <1% | 29 | $326.01 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 15 | $122.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMECHREFE, ADIB (MEDICAL DIRECTOR)